The University of Chicago Header Logo

Connection

Gini Fleming to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Gini Fleming has written about Protein Kinase Inhibitors.
Gini Fleming
Connection Strength
0.347
Protein Kinase Inhibitors
  1. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
    View in: PubMed
    Score: 0.292
  2. Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity. J Clin Oncol. 2008 Mar 01; 26(7):1119-27.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.